Gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with Siewert II/III AEG or proximal gastric cancer by endoscopy and histopathology; (2) Underwent radical proximal gastrectomy, with postoperative pathological examination confirming R0 resection; (3) Required additional surgical intervention after non-curative EMR or ESD; (4) Complete clinical and pathological data.
Exclusion criteria
Exclusion criteria: (1) Patients with other malignant tumors; (2) Patients with autoimmune diseases or immunodeficiency disorders; (3) Missing clinical and pathological data.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Complication Incidence;Postoperative 5-year disease-free survival time;Postoperative 5-year overall survival time;Albumin;Hemoglobin;Operation time;Scope of lymph node dissection;Blood loss;Laparoscopic conversion rate;Tumor size;Invasion depth;Number of lymph node metastases;Postoperative hospitalization time;Postgastrectomy Syndrome Assessment Scale-45;Mortality rate within 30 days after surgery;Degree of differentiation;Gastro-oesophageal reflux disease; | — |
Primary
| Measure | Time frame |
|---|---|
| The incidence of reflux esophagitis one year postoperatively;Body mass index; | — |
Countries
China
Contacts
Beijing Friendship Hospital, Capital Medical University